Vogipax MP 500 mg/7.5 mg/0.3 mg Tablet
Metformin (500mg) + Pioglitazone (7.5mg) + Voglibose (0.3mg)
Primary uses of : Type 2 diabetes
-
-
-
*
-
|
Composition
|
Metformin (500mg) + Pioglitazone (7.5mg) + Voglibose (0.3mg) |
|
Potentially Unsafe With
|
Alcohol |
|
Side Effect
|
Common
Nausea, Altered taste, Diarrhoea, Stomach pain, Edema (swelling), Weight gain, Respiratory tract infection, Skin rash, Blurred vision, Bone fracture. |
|
How to works
|
How Vogipax MP Tablet works
Vogipax MP 500 mg/7.5 mg/0.3 mg Tablet is a combination of three antidiabetic medicines: Metformin, pioglitazone and voglibose. They work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective. Metformin is a biguanide which decreases the production and absorption of sugar in your body and allows better use of existing insulin. Pioglitazone is a thiazolidinedione which works by increasing the body's sensitivity to insulin. Voglibose is an alpha-glucosidase inhibitor which inhibits the intestinal enzymes that cause breakdown of complex sugars into simple sugars such as glucose. This prevents blood glucose from rising very high after meals. |
